Medtronic Plc
Could not find a ticker for this position, may be a filing error
A maker of medical devices used by doctors and patients worldwide, from Micra pacemakers and Evolut heart-valve systems to Hugo surgical robots, Nellcor pulse oximeters, and insulin pumps. It began in 1949 when electrical engineer Earl Bakken and his brother-in-law Palmer Hermundslie started repairing medical equipment in a Minneapolis garage, coining the name by blending "medical" and "electronic." Four years later, Bakken built the world's first wearable, battery-powered pacemaker after a citywide power outage left heart patients vulnerable.
1.625% Senior Notes due 2013
Granted 1.33M · Bought 20.8K · Sold 361.9K
Granted 624.2K · Sold 118.5K
Granted 149.9K · Sold 50.4K
Granted 472.4K · Sold 223.5K
Granted 297.3K · Sold 78.7K
Granted 84.0K · Bought 33.7K
Granted 64.7K · Sold 2.2K
Granted 159.0K · Bought 3.0K · Sold 4.0K
Granted 233.6K · Sold 120.3K
Granted 138.7K · Sold 32.9K
Granted 74.3K · Sold 368
Granted 332.7K · Sold 361.0K
Granted 131.9K · Sold 75.7K
Granted 61.6K · Bought 13.7K · Sold 3.2K
Granted 57.5K · Bought 2.0K · Sold 1.3K
Granted 195.2K · Sold 113.7K
Granted 72.6K
Granted 77.0K · Sold 40.0K
Granted 56.2K · Sold 7.9K
Granted 215.6K · Sold 122.5K
Granted 67.3K
Granted 212.3K · Sold 167.5K
Granted 20.3K
Granted 37.3K
Granted 26.8K
Granted 69.6K · Sold 3.3K
Granted 39.5K
Granted 84.1K · Sold 65.3K
Granted 51.0K · Sold 34.7K
Granted 318.9K · Sold 240.2K
Granted 22.8K
Granted 268.5K · Sold 80.0K
Granted 25.7K
Granted 20.5K
Granted 22.8K
Granted 8.9K
Granted 11.2K
Granted 10.8K
Granted 7.8K
Granted 8.0K
Granted 1.4K · Bought 5.0K
Granted 6.0K
Granted 1.8K
Granted 1.4K
Granted 21.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Ishrak OmarExecutive Chairman, Director · 44 transactions | — | 1.76Mas of Dec 2020 | 1.33M | 20.8K | 361.9K |
| Martha GeoffreyChairman and CEO, Director · 58 transactions | — | 301.2K | 624.2K | — | 118.5K |
| OConnell Christopher JEVP & GroupPres Restora Therap · 7 transactions | — | 197.3Kas of Feb 2015 | 149.9K | — | 50.4K |
| Coyle Michael JEVP & Group Pres, Cardiac&Vasc · 32 transactions | — | 194.7Kas of Nov 2020 | 472.4K | — | 223.5K |
| Ellis Gary LeeEVP & Global Ops and IT · 12 transactions | — | 194.0Kas of Jan 2017 | 297.3K | — | 78.7K |
| Anderson Richard HDirector · 35 transactions | — | 120.3Kas of May 2023 | 84.0K | 33.7K | — |
| Marinaro MichaelEVP, Pres MedSurg and Americas · 25 transactions | — | 116.3K | 64.7K | — | 2.2K |
| Parkhill Karen LEVP & Chief Financial Officer · 50 transactions | — | 99.1Kas of Aug 2024 | 159.0K | 3.0K | 4.0K |
| Hanson Bryan CEVP, President, MITG · 25 transactions | — | 88.8Kas of Dec 2017 | 233.6K | — | 120.3K |
| Wall Brett A.EVP & Pres Neuroscience · 38 transactions | — | 82.2K | 138.7K | — | 32.9K |
| Oleary Denise MDirector · 30 transactions | — | 77.1Kas of May 2024 | 74.3K | — | 368 |
| Kuntz RichardSVP & Chief Medical & Science · 45 transactions | — | 74.9Kas of Nov 2021 | 332.7K | — | 361.0K |
| Salmon SeanEVP & President Cardiovascular · 34 transactions | — | 64.7Kas of Dec 2024 | 131.9K | — | 75.7K |
| Pozen Robert CDirector · 14 transactions | — | 64.2Kas of Aug 2018 | 61.6K | 13.7K | 3.2K |
| Lenehan James TDirector · 24 transactions | — | 57.8Kas of May 2021 | 57.5K | 2.0K | 1.3K |
| Ten Hoedt RobEVP and Pres. Global Regions · 44 transactions | — | 56.8Kas of Aug 2023 | 195.2K | — | 113.7K |
| Fong Ivan KEVP GENERAL COUNSEL & SECR · 15 transactions | — | 54.7Kas of Dec 2024 | 72.6K | — | — |
| Smith Gregory LEVP Global Ops & Supply Chain · 24 transactions | — | 51.8K | 77.0K | — | 40.0K |
| Powell Kendall JDirector · 32 transactions | — | 51.4K | 56.2K | — | 7.9K |
| White Robert JohnEVP & Pres. Medical Surgical · 48 transactions | — | 49.9Kas of Dec 2023 | 215.6K | — | 122.5K |
| Hogan Randall JDirector · 30 transactions | — | 49.0K | 67.3K | — | — |
| Lerman Bradley ESVP General Counsel & Corp Sec · 33 transactions | — | 48.6Kas of Nov 2021 | 212.3K | — | 167.5K |
| Corona Gary LouisInterim CFO · 3 transactions | — | 44.3Kas of Jan 2025 | 20.3K | — | — |
| Arnold CraigDirector · 25 transactions | — | 42.2K | 37.3K | — | — |
| Walter Matthew R.SVP, Chief HR Officer · 17 transactions | — | 38.7K | 26.8K | — | — |
| Jackson Shirley ADirector · 15 transactions | — | 38.5Kas of May 2018 | 69.6K | — | 3.3K |
| Pieton ThierryEVP & Chief Financial Officer · 4 transactions | — | 37.6K | 39.5K | — | — |
| Kiil Harry SkipEVP & President Cardiovascular · 19 transactions | — | 37.5K | 84.1K | — | 65.3K |
| Liddicoat John REVP & President of Americas · 16 transactions | — | 37.4Kas of Jul 2022 | 51.0K | — | 34.7K |
| Hakami HoomanEVP & Group President Diabetes · 43 transactions | — | 31.2Kas of Sep 2019 | 318.9K | — | 240.2K |
| Kirk Jennifer MChief Accounting Officer · 14 transactions | — | 28.0Kas of Dec 2024 | 22.8K | — | — |
| Surface Carol AEVP, Chief HR Officer · 39 transactions | — | 26.8Kas of Aug 2022 | 268.5K | — | 80.0K |
| Donnelly Scott CDirector · 26 transactions | — | 23.7K | 25.7K | — | — |
| Leavitt Michael ODirector · 9 transactions | — | 21.8Kas of May 2021 | 20.5K | — | — |
| Nabel Elizabeth GDirector · 24 transactions | — | 19.6K | 22.8K | — | — |
| Blomquist Denise L.Chief Accounting Officer · 17 transactions | — | 14.7K | 8.9K | — | — |
| Goldsmith Andrea JoDirector · 13 transactions | — | 10.2Kas of Apr 2025 | 11.2K | — | — |
| Lofton Kevin EDirector · 11 transactions | — | 10.1K | 10.8K | — | — |
| Reddy PreethaDirector · 5 transactions | — | 7.8Kas of May 2016 | 7.8K | — | — |
| Fonseca LidiaDirector · 7 transactions | — | 7.6K | 8.0K | — | — |
| Jellison William RDirector · 3 transactions | — | 6.4K | 1.4K | 5.0K | — |
| Lewis Gregory PDirector · 5 transactions | — | 5.8K | 6.0K | — | — |
| Lee Joon SupDirector · 1 transaction | — | 1.8K | 1.8K | — | — |
| Groetelaars John PDirector · 1 transaction | — | 1.4K | 1.4K | — | — |
| Quinn MichelleEVP, GC and Secretary · 2 transactions | — | 0as of Jul 2025 | 21.7K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -2.23M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.